User login
Is Routine 39-Week Induction of Labor in Healthy Pregnancy a Reasonable Course?
In this supplement to OBG Management a panel of experts discuss the risks and benefits of routine induction of labor (IOL) at 39 weeks. The panelists examine the findings from the ARRIVE trial and the potential impact on real-world practice. The experts also describe their own approach to IOL at 39 weeks and what they see for the future.
Panelists
- Errol R. Norwitz, MD, PhD, MBA (Moderator)
- Aaron B. Caughey, MD, PhD
- John T. Repke, MD
- Sindhu K. Srinivas, MD, MSCE
In this supplement to OBG Management a panel of experts discuss the risks and benefits of routine induction of labor (IOL) at 39 weeks. The panelists examine the findings from the ARRIVE trial and the potential impact on real-world practice. The experts also describe their own approach to IOL at 39 weeks and what they see for the future.
Panelists
- Errol R. Norwitz, MD, PhD, MBA (Moderator)
- Aaron B. Caughey, MD, PhD
- John T. Repke, MD
- Sindhu K. Srinivas, MD, MSCE
In this supplement to OBG Management a panel of experts discuss the risks and benefits of routine induction of labor (IOL) at 39 weeks. The panelists examine the findings from the ARRIVE trial and the potential impact on real-world practice. The experts also describe their own approach to IOL at 39 weeks and what they see for the future.
Panelists
- Errol R. Norwitz, MD, PhD, MBA (Moderator)
- Aaron B. Caughey, MD, PhD
- John T. Repke, MD
- Sindhu K. Srinivas, MD, MSCE
Update: MS in Minority Populations
Click here to read the supplement.
Historically, multiple sclerosis (MS) has not been commonly studied in minority populations. However, important challenges must be overcome to provide optimal MS treatment in this patient population. In this supplement from Neurology Reviews, Dr. Castro-Borrero discusses MS in African Americans and Hispanic Americans, including:
- Incidence, age of onset, and disease progression
- Barriers to optimal treatment
- Recommendations for improved MS management
About the Author
Click here to read the supplement.
Historically, multiple sclerosis (MS) has not been commonly studied in minority populations. However, important challenges must be overcome to provide optimal MS treatment in this patient population. In this supplement from Neurology Reviews, Dr. Castro-Borrero discusses MS in African Americans and Hispanic Americans, including:
- Incidence, age of onset, and disease progression
- Barriers to optimal treatment
- Recommendations for improved MS management
About the Author
Click here to read the supplement.
Historically, multiple sclerosis (MS) has not been commonly studied in minority populations. However, important challenges must be overcome to provide optimal MS treatment in this patient population. In this supplement from Neurology Reviews, Dr. Castro-Borrero discusses MS in African Americans and Hispanic Americans, including:
- Incidence, age of onset, and disease progression
- Barriers to optimal treatment
- Recommendations for improved MS management
About the Author
Scientific Abstracts; Skin Disease Education Foundation’s 43rd Annual Hawaii Dermatology Seminar
Highlights from the 2019 Society of Gynecologic Surgeons Scientific Meeting
- Rising to the challenges in gynecologic surgical care
- Anterior, apical, posterior: Vaginal anatomy for the gynecologic surgeon
- Beyond enhanced recovery after surgery
B. Star Hampton, MD
Professor
Department of Obstetrics and Gynecology
Division of Urogynecology and Reconstructive
Pelvic Surgery
The Warren Albert Medical School
of Brown University
Women & Infants Hospital
Providence, Rhode Island
Peter C. Jeppson, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of New Mexico School of Medicine
Albuquerque, New Mexico
Audra Jolyn Hill, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of Utah School of Medicine
Salt Lake City, Utah
Sunil Balgobin, MD
Assistant Professor
Department of Obstetrics and Gynecology
Division of Female Pelvic Medicine
and Reconstructive Surgery
University of Texas Southwestern Medical Center
Dallas, Texas
Sean C. Dowdy, MD
Professor and Chair
Division of Gynecologic Oncology
Mayo Clinic
Rochester, Minnesota
- Rising to the challenges in gynecologic surgical care
- Anterior, apical, posterior: Vaginal anatomy for the gynecologic surgeon
- Beyond enhanced recovery after surgery
B. Star Hampton, MD
Professor
Department of Obstetrics and Gynecology
Division of Urogynecology and Reconstructive
Pelvic Surgery
The Warren Albert Medical School
of Brown University
Women & Infants Hospital
Providence, Rhode Island
Peter C. Jeppson, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of New Mexico School of Medicine
Albuquerque, New Mexico
Audra Jolyn Hill, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of Utah School of Medicine
Salt Lake City, Utah
Sunil Balgobin, MD
Assistant Professor
Department of Obstetrics and Gynecology
Division of Female Pelvic Medicine
and Reconstructive Surgery
University of Texas Southwestern Medical Center
Dallas, Texas
Sean C. Dowdy, MD
Professor and Chair
Division of Gynecologic Oncology
Mayo Clinic
Rochester, Minnesota
- Rising to the challenges in gynecologic surgical care
- Anterior, apical, posterior: Vaginal anatomy for the gynecologic surgeon
- Beyond enhanced recovery after surgery
B. Star Hampton, MD
Professor
Department of Obstetrics and Gynecology
Division of Urogynecology and Reconstructive
Pelvic Surgery
The Warren Albert Medical School
of Brown University
Women & Infants Hospital
Providence, Rhode Island
Peter C. Jeppson, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of New Mexico School of Medicine
Albuquerque, New Mexico
Audra Jolyn Hill, MD
Assistant Professor
Division of Urogynecology
Department of Obstetrics and Gynecology
University of Utah School of Medicine
Salt Lake City, Utah
Sunil Balgobin, MD
Assistant Professor
Department of Obstetrics and Gynecology
Division of Female Pelvic Medicine
and Reconstructive Surgery
University of Texas Southwestern Medical Center
Dallas, Texas
Sean C. Dowdy, MD
Professor and Chair
Division of Gynecologic Oncology
Mayo Clinic
Rochester, Minnesota
Fundamentals of Gene Therapy: Addressing Gaps in Physician Education
Click here to read supplement.
Gene therapy is a contemporary therapeutic intervention with recent positive results and regulatory approvals either completed or expected in the next several years for various conditions. In this supplement, learn more about:
- Basic principles of gene therapy
- In vivo vs ex vivo methods of gene transfer
- Vector types
- Clinical Considerations
About the Author
Click here to read supplement.
Click here to read supplement.
Gene therapy is a contemporary therapeutic intervention with recent positive results and regulatory approvals either completed or expected in the next several years for various conditions. In this supplement, learn more about:
- Basic principles of gene therapy
- In vivo vs ex vivo methods of gene transfer
- Vector types
- Clinical Considerations
About the Author
Click here to read supplement.
Click here to read supplement.
Gene therapy is a contemporary therapeutic intervention with recent positive results and regulatory approvals either completed or expected in the next several years for various conditions. In this supplement, learn more about:
- Basic principles of gene therapy
- In vivo vs ex vivo methods of gene transfer
- Vector types
- Clinical Considerations
About the Author
Click here to read supplement.
Cost-Effective Treatment Option for von Willebrand Disease
Click here to read the supplement.
What can be done to provide a cost-effective treatment option for von Willebrand Disease?
Topics include:
- Review of Key Clinical Studies and Surgical Procedures
- Pharmacokinetics Comparison
- Pharmacoeconomic Comparisons
Click here to read the supplement.
Click here to read the supplement.
What can be done to provide a cost-effective treatment option for von Willebrand Disease?
Topics include:
- Review of Key Clinical Studies and Surgical Procedures
- Pharmacokinetics Comparison
- Pharmacoeconomic Comparisons
Click here to read the supplement.
Click here to read the supplement.
What can be done to provide a cost-effective treatment option for von Willebrand Disease?
Topics include:
- Review of Key Clinical Studies and Surgical Procedures
- Pharmacokinetics Comparison
- Pharmacoeconomic Comparisons
Click here to read the supplement.
Rare Neurological Disease Special Report
The 5th annual Rare Neurological Disease Special Report covers a wide range of topics related to rare neurological diseases. Nearly 20 bylined articles include overviews of specific diseases, discussions of translational science, reports on trends in diagnosis and screening, advice on resources for health care professionals, snapshots of emerging therapies, and more. This year’s issue has a special focus on genetics and the potential for genetic therapy to transform the treatment of rare diseases.
The 5th annual Rare Neurological Disease Special Report covers a wide range of topics related to rare neurological diseases. Nearly 20 bylined articles include overviews of specific diseases, discussions of translational science, reports on trends in diagnosis and screening, advice on resources for health care professionals, snapshots of emerging therapies, and more. This year’s issue has a special focus on genetics and the potential for genetic therapy to transform the treatment of rare diseases.
The 5th annual Rare Neurological Disease Special Report covers a wide range of topics related to rare neurological diseases. Nearly 20 bylined articles include overviews of specific diseases, discussions of translational science, reports on trends in diagnosis and screening, advice on resources for health care professionals, snapshots of emerging therapies, and more. This year’s issue has a special focus on genetics and the potential for genetic therapy to transform the treatment of rare diseases.